Slide background

Slide background
Slide background
Slide background

Loading Events
January
2020
23
X. William Yang, MD, PhD

4:00 PM — 6:00 PM

David Geffen School of Medicine at UCLA

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

X. William Yang, MD, PhD

Professor, Department of Psychiatry & Biobehavioral Sciences,
Center for Neurobehavioral Genetics, Semel Institute for Neuroscience & Human Behavior
David Geffen School of Medicine at UCLA

“Novel Scalable Molecular Genetic Tools to Study the Mammalian Brain and Brain Disorders”

 

REGISTER

 

4-5PM: Lecture & Audience Q&A
5-6PM: Networking & Cocktail Reception

 

A major challenge in studying the mammalian brain is its enormous complexity in terms of cell types and numbers, molecular interactions within and between cells, and their dynamic changes through development, aging, and experience. To begin understanding these processes, it is crucial to study the molecular and cellular biology of the intact brain at a scalable and reproducible manner. Here, Dr. Yang will first present an integrative mouse genetics and systems biology approach to evaluate a large number of candidate molecular targets for Huntington’s disease in vivo. He will also present a novel and generalizable genetic method for sparse labeling of the morphology of genetically-defined neurons in the brain. They envision these approaches may have the potential to enhance the resolution, scale, and reproducibility in studying the mammalian brain and brain disorders.

 

Acknowledgement: This research is supported by NIH BRAIN Initiative and CHDI Foundation, Inc.

 

Dr. X. William Yang completed his undergraduate education at Yale University, obtaining combined B.S./M.S. degrees from the Department of Molecular Biophysics & Biochemistry in 1991. He then completed M.D./Ph.D. training at Rockefeller University (Ph.D., 1998) and Weill Medical College of Cornell University (M.D., 2000). He co-invented (with Nathaniel Heintz) a powerful mouse genetic technology to engineer Bacterial Artificial Chromosomes (BACs) and to generate BAC transgenic mice. Dr. Yang’s own laboratory, established at UCLA in 2002, has made significant contributions to the development of novel BAC transgenic mouse models for human neurodegenerative disorders including Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease, and the use of such models to dissect disease mechanisms and identify therapeutic targets. The Yang lab has also applied novel genetic and systems biology approaches to study neuronal cell-type-specific gene expression, to decipher in vivo protein interaction and transcriptome networks for HD, and to study brain-wide morphology of genetically-defined neurons. Finally, the Yang lab studies the role of basal ganglia circuitry in the generation of normal and pathological behaviors. Dr. Yang is a recipient of BRAIN Initiative Awards from the National Institutes of Health, Brain Disorder Award from the McKnight Foundation, the HDF’s Leslie Gehry Brenner Prize for Innovation in Science in 2014, and is a member of the American Society for Clinical Investigation.

 

To learn more about Dr. Yang, visit his lab page.

 

Q&A Moderator:

Hemali Phatnani, PhD
Director, Center for Genomics of Neurodegenerative Disease
New York Genome Center

  • EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:00 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.

  • Workshops
  • Computational Cancer Genomics Working Group Evening Lectures
    Computational Cancer Genomics Working Group is led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center. This group will build collaborations that apply novel statistical approaches and population-level analyses to major cohorts in cancer genomics.

  • Neurodegenerative Disease Working Group Evening Lectures
    The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including Alzheimer’s, Parkinson’s and Huntington’s diseases. The NYGC has created a new Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center, with the objective of bringing together researchers from NYGC’s institutional founding members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neurodegenerative disease.

  • Neuropsychiatric Disease Working Group Evening Lectures
    The NYGC has created a new scientific working group with the objective of bringing together researchers from our Institutional Founding Members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neuropsychiatric disease.